000 01322 a2200349 4500
005 20250512212339.0
264 0 _c19850122
008 198501s 0 0 eng d
022 _a0163-7258
024 7 _a10.1016/0163-7258(84)90044-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPallavicini, M G
245 0 0 _aCytosine arabinoside: molecular, pharmacokinetic and cytokinetic considerations.
_h[electronic resource]
260 _bPharmacology & therapeutics
_c1984
300 _a207-38 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aColony-Forming Units Assay
650 0 4 _aCytarabine
_xmetabolism
650 0 4 _aCytidine Triphosphate
_xmetabolism
650 0 4 _aDNA
_xbiosynthesis
650 0 4 _aDNA Replication
_xdrug effects
650 0 4 _aDrug Resistance
650 0 4 _aHematopoietic Stem Cells
_xdrug effects
650 0 4 _aHumans
650 0 4 _aIntestine, Small
_xdrug effects
650 0 4 _aKinetics
773 0 _tPharmacology & therapeutics
_gvol. 25
_gno. 2
_gp. 207-38
856 4 0 _uhttps://doi.org/10.1016/0163-7258(84)90044-5
_zAvailable from publisher's website
999 _c6390366
_d6390366